A new group of Americans might soon have access to the COVID-19 vaccine as Pfizer concluded their vaccine is safe and effective for children ages 5 to 11. The drugmaker plans to submit for Emergency Use Authorization (EUA); this approval could come in the following weeks. The authorization could be welcome news for parents and caregivers concerned about their children, as CDC data shows a recent uptick in adolescents catching the disease. Keep reading to learn more about the impact that COVID-19 has on children and the vaccination effort for adolescents.
Read More >>>

View PDF